Conexeu SciencesCNXU
CNXU logo
Fair Value
US$25.34
Share price02 Jun
US$7.1871.7% undervalued intrinsic discount
Loading
1Yn/a
7D-8.13%

This small biotech is developing technology that could potentially change how tissue is rebuilt

AI & tech investor with over 15 years experience.

Published
02 Jun 26
Views
2.5k
Not Invested

Fair Value vs Share Price

US$25.34
vs US$7.1871.7% undervalued intrinsic discount
PastFuture-2m170m202320242025202620272028202920302031Revenue US$170.2mEarnings US$31.2m
4.3k%
Revenue growth
18.3%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Conexeu Sciences

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Adequate balance sheet with low risk.

Market capUS$189.2m
PB26.7x
Estimated Growth67.9%
Dividend YieldN/A
Full analysis

CEO & management

Miles Harrison
CEO
1.3yrs
CEO Tenure

Develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair.